NCT01861314 2026-03-19Bortezomib, Sorafenib Tosylate, and Decitabine in Treating Patients With Acute Myeloid LeukemiaNational Cancer Institute (NCI)Phase 1 Active not recruiting15 enrolled
NCT01371981 2025-11-26Bortezomib and Sorafenib Tosylate in Treating Patients With Newly Diagnosed Acute Myeloid LeukemiaNational Cancer Institute (NCI)Phase 3 Active not recruiting1,645 enrolled 32 charts